Insmed (INSM) Reports Positive Topline Results from Landmark ASPEN Study of Brensocatib

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. ANET
3. NKE
4. BE
5. PANW
6. CL
7. SNDK
8. TAP
9. DELL
10. ROIV

Go back to Insmed (INSM) Reports Positive Topline Results from Landmark ASPEN Study of Brensocatib
INSMED (NASDAQ: INSM) Delayed: 126.29 --0 (-0%)
Previous Close $126.29    52 Week High $19.30 
Open $126.29    52 Week Low $9.02 
Day High $126.29    P/E N/A 
Day Low $126.29    EPS $-1.69 
Volume 121